AIIMS doctor says COVAXIN trial participation reduced by 70-80 percent
"It is happening because people are thinking why to volunteer when a vaccine is coming for everyone soon," Dr Sanjay Rai, Professor of Community Medicine at AIIMS said.;
New Delhi: With the start of Covid vaccination an immediate future in India, the phase III clinical trial for indigenously-developed Bharat Biotech's vaccine candidate COVAXIN is witnessing a shortage of volunteer participation, with a high refusal rate 70 per cent to 80 per cent, a senior AIIMS doctor said on Wednesday.
"When the clinical trial began, we wanted 100 volunteers and received over 4500 applications. In phase II, we wanted 50 and received 4000 applications. In phase III, now when wanted 1500-2000 participants, we could only recruit about 200 participants as of now. It is happening because people are thinking why to volunteer when a vaccine is coming for everyone soon," Dr Sanjay Rai, Professor of Community Medicine at AIIMS told ANI.
Also Read:COVID-19 vaccine Sputnik V shows 91.4 percent efficacy in new trial: Report
Dr Rai said there is not much excitement for clinical trial as people are over-excited about the vaccine, and added that as per the guidelines of the Central government, in the first phase, vaccines will only be administered to priority groups.
"Fact is that, even if a vaccine comes, it'll be given to healthcare providers, frontline workers, elderly with co-morbidities first. But people think they will get vaccine soon," he added.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.